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Abstract Isatin is an important compound from the biolog-
ical aspect of view. It is an endogenous substance and
moreover; various pharmacological activities have been
reported for isatin and its derivatives. In-vitro cytotoxic
effects of the prepared isatin Schiff bases toward HeLa,
LS180 and Raji human cancer cell lines has been reported
in our previous work. 3-(2-(4-nitrophenyl)hydrazono)
indolin-2-one was found to be the most potent one among
the studied compounds (IC30012.2 and 21.8 μM in HeLa
and LS-180 cell lines, respectively). Obtained biological
data could be well interpreted using docking binding ener-
gies toward vascular endothelial growth factor receptor
(VEGFR-2); a key anticancer target being biologically in-
vestigated against various isatin derivatives. In the present
work, quantum mechanical (QM) method including func-
tional B3LYP in association with split valence basis set
using polarization functions (Def2-SVP) was used to esti-
mate individual ligand-residue interaction energies for the
docked 3-(2-(4-nitrophenyl)hydrazono) indolin-2-one into
VEGFR-2 active site. Results were further interpreted via
calculated polarization effects induced by individual amino
acids of the receptor active site. A fairly good correlation
could be found between polarization effects and estimated
binding energies (R200.7227). Conformational analysis
revealed that 3-(2-(4-nitrophenyl) hydrazono) indolin-2-
one might not necessarily interact with the VEGFR-2 active
site in its minimum energy conformation.
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Introduction
Isatin is a natural product found in a number of plants
including those of the genus Isatis [1]. It has also been
found as a metabolic derivative of adrenaline in humans
[2]. Moreover, it has been demonstrated that isatin is found
at higher levels in patients involved with neuropathological
conditions and also proved to be a competitive MAO-B
inhibitor [3, 4]. Various derivatives of isatin are known to
possess a range of pharmacological properties including
antiprotozoal [5, 6], antiglycation [7], anticonvulsant and
sedative-hypnotic [8, 9], anti-inflammatory [10], anti-
bacterial and anti-fungal [11] activities. Thus isatin is a
biologically validated starting point for the design and syn-
thesis of chemical libraries directed at these targets [12].
Due to the privileged nature of isatin, libraries designed and
synthesized around the basic structure of this scaffold may
yield medicinally active compounds with high hit rates.
In a typical lead/drug discovery protocol, potential can-
didate molecules may suffer from undesirable properties in
their pharmacokinetic and pharmacodynamic profiles.
Structure-based drug design has been considered as one of
the major strategies in achieving potential drug candidates
[13, 14]. In lead-drug development strategies, combination
of experimental methods with computer aided molecular
design (CAMD) techniques is essential for the development
of new drugs aimed at new targets, and thus for medicinal
chemistry [15].
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